In less than a month, from August 20 to September 19, amivantamab (Ami; Rybrevant, Johnson & Johnson) received 2 approvals ...

Panelists discuss how HER2-directed therapies in non–small cell lung cancer (NSCLC) are evolving, with experts examining the distinction between HER2 mutation and expression, evaluating the efficacy ...

A French study found that follitropin alfa, a biosimilar fertility drug, is more cost-effective compared with its originator, ...

Average Medicare drug premiums for older Americans will drop next year for those enrolled in traditional Medicare plans or ...

Survey reveals gaps in vaccination intentions for flu, COVID-19, respiratory syncytial virus, and pneumococcal disease.

Clyde Yancy, MD, MSc, FHFSA, professor, chief of cardiology, and vice dean of diversity and inclusion at Northwestern ...

Systemic racism, including the practice of redlining, has had an enduring effect on health outcomes in people living with HIV ...

Despite reductions in deaths from cancer and cardiovascular diseases, increased mortality from assaults, accidents, and the ...

While previous trials have led to questions surrounding the potential benefits of valve interventions in mitral or tricuspid regurgitation, a pair of trials presented recently demonstrate their ...

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our ...

While AI's role in clinical trial design and real-time monitoring is well-known, it also brings unprecedented potential in ...

September marked Ovarian Cancer Awareness Month, highlighting the importance of early detection and the need for equitable ...